Demo Sign up Log In

Esperion Therapeutics Inc (ESPR)

Revenue Per Share

0.32

Quarterly · Period ending: Mar 31, 2026

ESPR Revenue Per Share

Latest reported0.32period endingMar 31, 2026

Latest reported0.32period endingMar 31, 2026

ESPR Quarterly Revenue per Share (0.00 → 0.32)

Period values, visible window

High-resolution chart · PNG

ESPR revenue per share history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc Revenue Per Share — Quarterly
Period ending	Revenue Per Share
Mar 31, 2026	0.3187
Dec 31, 2025	0.7117
Sep 30, 2025	0.4406
Jun 30, 2025	0.4185
Mar 31, 2025	0.3314
Dec 31, 2024	0.3534
Sep 30, 2024	0.2649
Jun 30, 2024	0.3911
Mar 31, 2024	0.8138
Dec 31, 2023	0.2869
Sep 30, 2023	0.3036
Jun 30, 2023	0.236
Mar 31, 2023	0.3102
Dec 31, 2022	0.2561
Sep 30, 2022	0.2799
Jun 30, 2022	0.298
Mar 31, 2022	0.309
Dec 31, 2021	0.418
Sep 30, 2021	0.5447
Jun 30, 2021	1.5504
Mar 31, 2021	0.3069
Dec 31, 2020	0.3585
Sep 30, 2020	0.1377
Jun 30, 2020	7.6714
Mar 31, 2020	0.0669
Dec 31, 2019	0.0359
Sep 30, 2019	0.0361
Jun 30, 2019	0.0364
Mar 31, 2019	5.4174
Dec 31, 2018	6.8787
Sep 30, 2018	0
Jun 30, 2018	0
Mar 31, 2018	0
Dec 31, 2017	0
Sep 30, 2017	0
Jun 30, 2017	0
Mar 31, 2017	0
Dec 31, 2016	0
Sep 30, 2016	0
Jun 30, 2016	0
Mar 31, 2016	0
Dec 31, 2015	0
Sep 30, 2015	0
Jun 30, 2015	0
Mar 31, 2015	0
Dec 31, 2014	0
Sep 30, 2014	0
Jun 30, 2014	0
Mar 31, 2014	0
Dec 31, 2013	0
Sep 30, 2013	0
Jun 30, 2013	0
Mar 31, 2013	0
Dec 31, 2012	0
Sep 30, 2012	0
Jun 30, 2012	0
Mar 31, 2012	0
Sep 30, 2003	0
Jun 30, 2003	0
Mar 31, 2003	0
Dec 31, 2002	0
Sep 30, 2002	0
Jun 30, 2002	0
Mar 31, 2002	0
Dec 31, 2001	0
Sep 30, 2001	0
Jun 30, 2001	0.0003
Mar 31, 2001	0.0003
Dec 31, 2000	0.0005
Sep 30, 2000	0.0005
Jun 30, 2000	0.0032
Mar 31, 2000	0.0004

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.